KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xylem (XYL) Total Current Liabilities (2016 - 2025)

Xylem (XYL) has 16 years of Total Current Liabilities data on record, last reported at $2.9 billion in Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 22.26% year-over-year to $2.9 billion; the TTM value through Dec 2025 reached $2.9 billion, up 22.26%, while the annual FY2025 figure was $2.9 billion, 22.26% up from the prior year.
  • Total Current Liabilities reached $2.9 billion in Q4 2025 per XYL's latest filing, up from $2.3 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $2.9 billion in Q4 2025 and bottomed at $1.3 billion in Q3 2021.
  • Average Total Current Liabilities over 5 years is $2.0 billion, with a median of $2.0 billion recorded in 2024.
  • Peak YoY movement for Total Current Liabilities: fell 28.89% in 2021, then surged 56.02% in 2024.
  • A 5-year view of Total Current Liabilities shows it stood at $1.4 billion in 2021, then grew by 14.31% to $1.6 billion in 2022, then skyrocketed by 38.68% to $2.2 billion in 2023, then increased by 5.94% to $2.3 billion in 2024, then grew by 22.26% to $2.9 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $2.9 billion in Q4 2025, $2.3 billion in Q3 2025, and $2.3 billion in Q2 2025.